News & Articles

New research assesses the interaction between the SARS-CoV-2 Spike S1 protein receptor binding domain (SARS-CoV-2 S1 RBD) and heparin

Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SCB-2019

Investment in state-of-the-art automation cements Abingdon Health’s position as a leading global rapid test manufacturer

Reliable, easy-to-use cryo-EM workflow solution promises to quadruple throughput for pharma labs

Our new expert webinar series aims to help you get the most from your microbiology research

The company is providing well-characterized and standardized human primary cells with matching specialty cell culture media

Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs

These four viral infections have similar patient presentations, making accurate detection and differentiation critical during next flu season

Additional real-world data demonstrate meaningful outcomes for people living with diabetes who use Abbott's glucose sensing technology

The RECOVERY trial has shown that the cheap and widely available steroid cut deaths by one-third among patients critically ill with COVID-19

The test detects antibodies made by the immune system in response to infection by the novel coronavirus in as little as 10 minutes

It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.

Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London

Increase the effectiveness of human vaccines against infectious diseases such as COVID-19

Join this expert webinar to discover the complexities and challenges for wide patient access to new chimeric antigen receptor T (CAR-T) cell therapies

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers

Company exploring further additional global capacity to provide broad and equitable access